Currently in August, the United States drugmaker’s chief executive officer claimed the firm anticipated Tirzepatide to be gotten rid of from the scarcity listing.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/eli-lillys-tirzepatide-drugs-removed-from-fda-shortage-list/